XBI ETF largest holding is MRNA at 1.62% as of Jun 30, 2026
State Street SPDR S&P Biotech ETF
MRNA is XBI's largest holding at 1.62% of the fund as of Jun 30, 2026. XBI is State Street SPDR S&P Biotech ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Moderna therapeuticsHealth Care · Biotechnology | 1.62% | 1.6% | 2,156,891 | +464.5K | Health Care | Biotechnology |
| 2 | A | Apogee Therapeutics IncHealth Care · Biotechnology | 1.47% | 3.1% | 1,199,234 | -69.0K | Health Care | Biotechnology |
| Share changes, sector and industry · Pro | ||||||||
| 3 | T | Twist Bioscience Corp. | 1.35% | 4.4% | 1,463,691 | |||
| 4 | K | Kymera Therapeutics Inc | 1.34% | 5.8% | 1,268,064 | |||
| 5 | E | Erasca Inc. | 1.29% | 7.1% | 7,419,695 | |||
| 6 | V | Viking Therapeutics Inc | 1.27% | 8.3% | 3,574,768 | |||
| 7 | N | Natera Inc | 1.20% | 9.5% | 458,237 | |||
| 8 | R | Revolution Medicines Inc | 1.20% | 10.7% | 687,949 | |||
| 9 | O | Oruka Therapeutics Inc Orka | 1.19% | 11.9% | 1,549,262 | |||
| 10 | P | Praxis Precision Medicines, Inc. | 1.19% | 13.1% | 412,207 | |||
| 11 | R | Rhythm Pharmaceuticals Inc | 1.19% | 14.3% | 1,157,392 | |||
| 12 | M | Mirum Pharmaceuticals Inc | 1.18% | 15.5% | 1,055,296 | |||
| 13 | C | Cytokinetics Inc | 1.17% | 16.7% | 1,478,986 | |||
| 14 | C | Cg Oncology Inc | 1.15% | 17.8% | 1,806,242 | |||
| 15 | C | Cogent Biosciences Inc | 1.15% | 19.0% | 3,161,289 | |||
| 16 | S | Scholar Rock Holding Corp | 1.15% | 20.1% | 2,249,906 | |||
| 17 | P | Vaxcyte Inc | 1.15% | 21.3% | 2,184,031 | |||
| 18 | — | Alkermes Plc. Ordinary Shares | 1.15% | 22.4% | 2,262,805 | |||
| 19 | P | Protagonist Therapeutics Inc | 1.14% | 23.5% | 937,897 | |||
| 20 | — | Roivant Sciences Ltd. Common Shares | 1.14% | 24.7% | 3,491,718 | |||
| 21 | — | Crispr Therapeutics Ag Common Shares | 1.14% | 25.8% | 2,006,430 | |||
| 22 | R | Ultragenyx Pharmaceutical Inc | 1.13% | 27.0% | 3,653,348 | |||
| 23 | A | Arrowhead Pharmaceuticals Inc | 1.12% | 28.1% | 1,402,397 | |||
| 24 | C | Celcuity Inc | 1.12% | 29.2% | 1,124,179 | |||
| 25 | D | Dianthus Therapeutics Inc | 1.12% | 30.3% | 1,298,103 | |||
| 26 | T | Travere Therapeutics Inc | 1.12% | 31.4% | 2,122,275 | |||
| 27 | I | Insmed Inc | 1.11% | 32.5% | 1,079,724 | |||
| 28 | S | Sellas Life Sciences Group Inc. | 1.11% | 33.7% | 8,622,810 | |||
| 29 | — | Nvaesrtex Pharmaceuticals Inc | 1.11% | 34.8% | 227,635 | |||
| 30 | K | Krystal Biotech Inc | 1.10% | 35.9% | 317,561 | |||
| 31 | B | Beam Therapeutics Inc | 1.09% | 37.0% | 3,363,830 | |||
| 32 | R | Relay Therapeutics Inc | 1.09% | 38.1% | 6,281,451 | |||
| 33 | S | Summit Therapeutics Inccommon Stock | 1.09% | 39.1% | 7,425,647 | |||
| 34 | T | Tg Therapeutics Inc | 1.09% | 40.2% | 2,127,835 | |||
| 35 | S | Spyre Therapeutics Inc | 1.08% | 41.3% | 1,321,145 | |||
| 36 | P | Ptc Therapeutics Inc | 1.06% | 42.4% | 1,352,456 | |||
| 37 | B | Bridgebio Pharma Inc | 1.05% | 43.4% | 1,471,731 | |||
| 38 | H | Halozyme Therapeutics Inc | 1.05% | 44.5% | 1,407,148 | |||
| 39 | I | Ionis Pharmaceuticals Inc | 1.04% | 45.5% | 1,353,002 | |||
| 40 | A | AbbVie Inc. | 1.03% | 46.5% | 440,973 | |||
| 41 | M | Madrigal Pharmaceuticals Inc | 1.03% | 47.6% | 210,471 | |||
| 42 | I | Immunitybio Inc | 1.02% | 48.6% | 12,449,949 | |||
| 43 | I | Incyte Corp. | 1.00% | 49.6% | 941,442 | |||
| 44 | A | Amgen Inc. | 0.99% | 50.6% | 293,773 | |||
| 45 | N | Neurocrine Biosciences Inc | 0.99% | 51.6% | 616,686 | |||
| 46 | R | Regeneron Pharmaceuticals, Inc. | 0.99% | 52.6% | 164,860 | |||
| 47 | A | Alnylam Pharmaceuticals Inc. | 0.98% | 53.5% | 340,627 | |||
| 48 | B | Biogen Inc. | 0.98% | 54.5% | 510,666 | |||
| 49 | V | Vera Therapeutics Inc Ser C Pc Pp | 0.98% | 55.5% | 2,640,417 | |||
| 50 | G | Gilead Sciences | 0.97% | 56.5% | 816,553 | |||
| More holdings · Pro | ||||||||
XBI ETF All Holdings
XBI holdings total 157 positions. The top 10 holdings account for 13.1% of the fund, led by Moderna therapeutics at 1.6%, Apogee Therapeutics Inc at 1.5%, Twist Bioscience Corp. at 1.4%.
XBI portfolio concentration is well-diversified, with the top 10 representing 13.1% of total assets. The largest sector exposure is Health Care at 98.0%.
XBI sectors provide a detailed breakdown. XBI overlap shows how holdings compare to other funds in your portfolio.
XBI ETF Holdings
160 of 157 holdings
- 1
Moderna therapeutics
MRNAHealth Care1.62% - 2
Apogee Therapeutics Inc
APGEHealth Care1.47% - 3
Twist Bioscience Corp.
TWSTHealth Care1.35% - 4
Kymera Therapeutics Inc
KYMRHealth Care1.34% - 5
Erasca Inc.
ERASHealth Care1.29% - 6
Viking Therapeutics Inc Com
VKTXHealth Care1.27% - 7
Natera Inc
NTRAHealth Care1.20% - 8
Revolution Medicines Inc
RVMDHealth Care1.20% - 9
Oruka Therapeutics Inc Orka
ORKAHealth Care1.19% - 10
Praxis Precision Medicines, Inc.
PRAXHealth Care1.19% - 11
Rhythm Pharmaceuticals Inc
RYTMHealth Care1.19% - 12
Mirum Pharmaceuticals Inc
MIRMHealth Care1.18% - 13
Cytokinetics Inc
CYTKHealth Care1.17% - 14
Cg Oncology Inc
CGONHealth Care1.15% - 15
Cogent Biosciences Inc
COGTHealth Care1.15% - 16
Scholar Rock Holding Corp
SRRKHealth Care1.15% - 17
Vaxcyte Inc
PCVXHealth Care1.15% - 18
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care1.15% - 19
Protagonist Therapeutics Inc
PTGXHealth Care1.14% - 20
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.14% - 21
Crispr Therapeutics Ag Common Shares
CRSP:SMHealth Care1.14% - 22
Ultragenyx Pharmaceutical Inc
RAREHealth Care1.13% - 23
Arrowhead Pharmaceuticals Inc
ARWRHealth Care1.12% - 24
Celcuity Inc Com
CELCHealth Care1.12% - 25
Dianthus Therapeutics Inc
DNTHHealth Care1.12% - 26
Travere Therapeutics Inc
TVTXHealth Care1.12% - 27
Insmed Inc
INSMHealth Care1.11% - 28
Sellas Life Sciences Group Inc.
SLSHealth Care1.11% - 29
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care1.11% - 30
Krystal Biotech Inc
KRYSHealth Care1.10% - 31
Beam Therapeutics Inc
BEAMHealth Care1.09% - 32
Relay Therapeutics Inc
RLAYHealth Care1.09% - 33
Summit Therapeutics Inccommon Stock
SMMTHealth Care1.09% - 34
Tg Therapeutics Inc Common Stock
TGTXHealth Care1.09% - 35
Spyre Therapeutics Inc
SYREHealth Care1.08% - 36
Ptc Therapeutics Inc
PTCTHealth Care1.06% - 37
Bridgebio Pharma Inc
BBIOHealth Care1.05% - 38
Halozyme Therapeutics Inc
HALOHealth Care1.05% - 39
Ionis Pharmaceuticals Inc
IONSHealth Care1.04% - 40
Abbvie Inc.
ABBVHealth Care1.03% - 41
Madrigal Pharmaceuticals Inc
MDGLHealth Care1.03% - 42
Immunitybio Inc
IBRXHealth Care1.02% - 43
Incyte Corp.
INCYHealth Care1.00% - 44
Amgen Inc.
AMGNHealth Care0.99% - 45
Neurocrine Biosciences Inc
NBIXHealth Care0.99% - 46
Regeneron Pharmaceuticals, Inc.
REGNHealth Care0.99% - 47
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.98% - 48
Biogen Inc. Com
BIIBHealth Care0.98% - 49
Vera Therapeutics Inc Ser C Pc Pp
VERAHealth Care0.98% - 50
Gilead Sciences
GILDHealth Care0.97% - 51
Biomarin Pharmaceutical Inc.
BMRNHealth Care0.96% - 52
Exelixis Inc
EXELHealth Care0.96% - 53
Acadia Pharmaceuticals Inc
ACADHealth Care0.94% - 54
Intellia Therapeutics Inc
NTLAHealth Care0.94% - 55
Nuvalent
NUVLHealth Care0.92% - 56
United Therapeutics Corp
UTHRHealth Care0.92% - 57
Immunovant Inc
IMVTHealth Care0.91% - 58
Uniqure N.V. Ordinary Shares
QURE:ASHealth Care0.91% - 59
Grail Inc Common Stock Usd
GRALHealth Care0.90% - 60
BioCryst Pharmaceuticals Inc.
BCRXHealth Care0.89% - 61
Dyne Therapeutics Inc
DYNHealth Care0.87% - 62
Catalyst Partners Acquisition Corp Ieu
CPARUHealth Care0.86% - 63
Ideaya Biosciences Inc
IDYAHealth Care0.84% - 64
Denali Therapeutics Inc
DNLIHealth Care0.82% - 65
RECURSION PHARMACEUTICALS-A
RXRXHealth Care0.80% - 66
Veracyte Inc
VCYTHealth Care0.80% - 67
Tango Therapeutics Inc.
TNGXHealth Care0.79% - 68
Sarepta Therapeutics Inc
SRPTHealth Care0.78% - 69
Mineralys Therapeutics Inc
MLYSHealth Care0.75% - 70
Arcus Biosciences Inc
RCUSHealth Care0.71% - 71
Celldex Therapeutics Inc
CLDXHealth Care0.71% - 72
Syndax Pharmaceuticals Inc
SNDXHealth Care0.71% - 73
Arcutis Biotherapeutics Inc
ARQTHealth Care0.70% - 74
Agios Pharmaceuticals Inc
AGIOHealth Care0.69% - 75
Disc Medicine Inc
IRONHealth Care0.68% - 76
Viridian Therapeutics Inc
VRDNHealth Care0.68% - 77
Immunome Inc
IMNMHealth Care0.66% - 78
Adma Biologics Inc Com
ADMAHealth Care0.65% - 79
Novavax Inc
NVAXHealth Care0.65% - 80
Iovance Biotherapeutics Inc
IOVAHealth Care0.56% - 81
Biohaven Ltd
BHVNUnknown0.56% - 82
Absci Corp
ABSIHealth Care0.55% - 83
Nurix Therapeutics Inc
NRIXHealth Care0.54% - 84
Palvella Therapeutics Inc
PVLAHealth Care0.53% - 85
Hyperliquid Strategies Inc
PURRUnknown0.51% - 86
Kodiak Sciences Inc
KODHealth Care0.51% - 87
Vericel Corp
VCELHealth Care0.51% - 88
Stoke Therapeuti
STOKHealth Care0.47% - 89
Anaptysbio Inc
ANABHealth Care0.45% - 90
Capricor Therapeutics Inc
CAPRHealth Care0.45% - 91
Monte Rosa Therapeutics Inc
GLUEHealth Care0.45% - 92
Vir Biotechnology Inc
VIRHealth Care0.45% - 93
Corvus Pharmaceuticals Inc
CRVSHealth Care0.41% - 94
Cullinan Therapeutics Inc
CGEMHealth Care0.39% - 95
Tyra Biosciences Inc
TYRAHealth Care0.39% - 96
Avalo Therapeuti
AVTXHealth Care0.37% - 97
Ardelyx Inc
ARDXHealth Care0.36% - 98
Inhibrx Biosciences Inc
INBXHealth Care0.36% - 99
Precigen Corp
PGENHealth Care0.36% - 100
Annexon Inc
ANNXHealth Care0.34% - 101
Mannkind Corp.
MNKDHealth Care0.33% - 102
Oric Pharmaceuticals, Inc. Series C
ORICHealth Care0.33% - 103
Taysha Gene Therapies Inc
TSHAHealth Care0.33% - 104
Zenas Biopharma Inc
ZBIOHealth Care0.33% - 105
Olema Pharmaceuticals Inc
OLMAHealth Care0.32% - 106
Vor Biopharma Inc
VORHealth Care0.32% - 107
Kura Oncology Inc
KURAHealth Care0.31% - 108
Jade Biosciences Inc
JBIOHealth Care0.30% - 109
Caredx Inc
CDNAHealth Care0.30% - 110
Bicara Therapeutics, Inc.
BCAXHealth Care0.29% - 111
Geron Corp
GERNHealth Care0.29% - 112
Replimune Group Inc Com
REPLHealth Care0.29% - 113
ARRIVENT BIOPHARMA INC
AVBPHealth Care0.28% - 114
Cytomx Therapeutics Inc
CTMXHealth Care0.28% - 115
Janux Therapeutics Inc
JANXHealth Care0.27% - 116
Regenxbio Inc
RGNXHealth Care0.27% - 117
Sana Biotechnology Inc Common Stock Usd.0001
SANAHealth Care0.26% - 118
Sionna Therapeutics Inc
SIONHealth Care0.26% - 119
Solid Biosciences Inc
SLDBHealth Care0.26% - 120
Xencor Inc
XNCRHealth Care0.26% - 121
Rigel Pharmaceuticals Inc
RIGLUnknown0.24% - 122
Allogene Therapeutics Inc
ALLOHealth Care0.23% - 123
Altimmune Inc
ALTHealth Care0.23% - 124
Ironwood Pharmaceuticals Inc
IRWDHealth Care0.22% - 125
Damora Therapeutics Inc
DMRAHealth Care0.20% - 126
Immix Biopharma Inc
IMMXHealth Care0.20% - 127
Candel Therapeutics Inc.
CADLHealth Care0.19% - 128
4d Molecular Therapeutics Inc.
FDMTHealth Care0.19% - 129
Ocugen Inc.
OCGNHealth Care0.19% - 130
Prime Medicine Inc Common Stock USD.00001
PRMEHealth Care0.19% - 131
Savara Inc
SVRAHealth Care0.18% - 132
Arbutus Biopharma Corp.
ABUSHealth Care0.17% - 133
First Tracks Biotherapeutics, Inc.
TRAXUnknown0.17% - 134
Myriad Genetics, Inc.
MYGNHealth Care0.17% - 135
ARS Pharmaceuticals Inc
SPRYHealth Care0.17% - 136
Maplight Therapeutics Inc
MPLTUnknown0.16% - 137
Cabaletta Bio Inc
CABAHealth Care0.15% - 138
COMPASS THERAPEUTICS INC
CMPXHealth Care0.14% - 139
Verastem Inc
VSTMUnknown0.14% - 140
Emergent Biosolutions Inc
EBSHealth Care0.13% - 141
Perspective Ther
CATXHealth Care0.13% - 142
Vanda Pharmaceuticals Inc
VNDAHealth Care0.13% - 143
Prothena Corporation Public Limited Company Ordinary Shares
PRTA:IEHealth Care0.13% - 144
Ovid Therapeutics Inc
OVIDHealth Care0.12% - 145
Mimedx Group Inc Com
MDXGHealth Care0.11% - 146
Lexeo Therapeutics Inc - Series B
LEXOHealth Care0.10% - 147
Achieve Life Sciences Inc
ACHVHealth Care0.08% - 148
Sagimet Biosciences Inc
SGMTHealth Care0.07% - 149
Contra Metsera Inc
Other0.07% - 150
BRIDGEBIO ONCOLOGY THERAPEUTICS IN
BBOTUnknown0.06% - 151
State Street Institutional US Government Money Market Fund
GVMXXFinancials0.04% - 152
Ping An Insu Ran Ce Group Co. Of C Hin A Ltd.
601318:SHHealth Care0.01% - 153
Contra Verve Therapeut
Other0.01% - 154
Contra Inhibrx Inc
Other0.01% - 155
Contra Akero Therapeut Common Stock
Other0.01% - 156
Atrium Therapeutics Inc
RNAUnknown0.00% - 157
Omniab Inc 12.5 Earnout
OABIHealth Care0.00% - 158
Omniab Inc 15.00 Earnout
OABIHealth Care0.00% - 159
US Dollar
Other0.00% - 160
Contra Blueprint Medic
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Moderna therapeutics | MRNA | 1.620% | ||
| 2 | Apogee Therapeutics Inc | APGE | 1.470% | ||
| 3 | Twist Bioscience Corp. | TWST | 1.350% | ||
| 4 | Kymera Therapeutics Inc | KYMR | 1.340% | ||
| 5 | Erasca Inc. | ERAS | 1.290% | ||
| 6 | Viking Therapeutics Inc Com | VKTX | 1.270% | ||
| 7 | Natera Inc | NTRA | 1.200% | ||
| 8 | Revolution Medicines Inc | RVMD | 1.200% | ||
| 9 | Oruka Therapeutics Inc Orka | ORKA | 1.190% | ||
| 10 | Praxis Precision Medicines, Inc. | PRAX | 1.190% | ||
| 11 | Rhythm Pharmaceuticals Inc | RYTM | 1.190% | ||
| 12 | Mirum Pharmaceuticals Inc | MIRM | 1.180% | ||
| 13 | Cytokinetics Inc | CYTK | 1.170% | ||
| 14 | Cg Oncology Inc | CGON | 1.150% | ||
| 15 | Cogent Biosciences Inc | COGT | 1.150% | ||
| 16 | Scholar Rock Holding Corp | SRRK | 1.150% | ||
| 17 | Vaxcyte Inc | PCVX | 1.150% | ||
| 18 | Alkermes Plc. Ordinary Shares | ALKS:IE | 1.150% | ||
| 19 | Protagonist Therapeutics Inc | PTGX | 1.140% | ||
| 20 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.140% | ||
| 21 | Crispr Therapeutics Ag Common Shares | CRSP:SM | 1.140% | ||
| 22 | Ultragenyx Pharmaceutical Inc | RARE | 1.130% | ||
| 23 | Arrowhead Pharmaceuticals Inc | ARWR | 1.120% | ||
| 24 | Celcuity Inc Com | CELC | 1.120% | ||
| 25 | Dianthus Therapeutics Inc | DNTH | 1.120% | ||
| 26 | Travere Therapeutics Inc | TVTX | 1.120% | ||
| 27 | Insmed Inc | INSM | 1.110% | ||
| 28 | Sellas Life Sciences Group Inc. | SLS | 1.110% | ||
| 29 | Nvaesrtex Pharmaceuticals Inc | VRTX | 1.110% | ||
| 30 | Krystal Biotech Inc | KRYS | 1.100% | ||
| 31 | Beam Therapeutics Inc | BEAM | 1.090% | ||
| 32 | Relay Therapeutics Inc | RLAY | 1.090% | ||
| 33 | Summit Therapeutics Inccommon Stock | SMMT | 1.090% | ||
| 34 | Tg Therapeutics Inc Common Stock | TGTX | 1.090% | ||
| 35 | Spyre Therapeutics Inc | SYRE | 1.080% | ||
| 36 | Ptc Therapeutics Inc | PTCT | 1.060% | ||
| 37 | Bridgebio Pharma Inc | BBIO | 1.050% | ||
| 38 | Halozyme Therapeutics Inc | HALO | 1.050% | ||
| 39 | Ionis Pharmaceuticals Inc | IONS | 1.040% | ||
| 40 | Abbvie Inc. | ABBV | 1.030% | ||
| 41 | Madrigal Pharmaceuticals Inc | MDGL | 1.030% | ||
| 42 | Immunitybio Inc | IBRX | 1.020% | ||
| 43 | Incyte Corp. | INCY | 1.000% | ||
| 44 | Amgen Inc. | AMGN | 0.990% | ||
| 45 | Neurocrine Biosciences Inc | NBIX | 0.990% | ||
| 46 | Regeneron Pharmaceuticals, Inc. | REGN | 0.990% | ||
| 47 | Alnylam Pharmaceuticals Inc. | ALNY | 0.980% | ||
| 48 | Biogen Inc. Com | BIIB | 0.980% | ||
| 49 | Vera Therapeutics Inc Ser C Pc Pp | VERA | 0.980% | ||
| 50 | Gilead Sciences | GILD | 0.970% | ||
| 51 | Biomarin Pharmaceutical Inc. | BMRN | 0.960% | ||
| 52 | Exelixis Inc | EXEL | 0.960% | ||
| 53 | Acadia Pharmaceuticals Inc | ACAD | 0.940% | ||
| 54 | Intellia Therapeutics Inc | NTLA | 0.940% | ||
| 55 | Nuvalent | NUVL | 0.920% | ||
| 56 | United Therapeutics Corp | UTHR | 0.920% | ||
| 57 | Immunovant Inc | IMVT | 0.910% | ||
| 58 | Uniqure N.V. Ordinary Shares | QURE:AS | 0.910% | ||
| 59 | Grail Inc Common Stock Usd | GRAL | 0.900% | ||
| 60 | BioCryst Pharmaceuticals Inc. | BCRX | 0.890% | ||
| 61 | Dyne Therapeutics Inc | DYN | 0.870% | ||
| 62 | Catalyst Partners Acquisition Corp Ieu | CPARU | 0.860% | ||
| 63 | Ideaya Biosciences Inc | IDYA | 0.840% | ||
| 64 | Denali Therapeutics Inc | DNLI | 0.820% | ||
| 65 | RECURSION PHARMACEUTICALS-A | RXRX | 0.800% | ||
| 66 | Veracyte Inc | VCYT | 0.800% | ||
| 67 | Tango Therapeutics Inc. | TNGX | 0.790% | ||
| 68 | Sarepta Therapeutics Inc | SRPT | 0.780% | ||
| 69 | Mineralys Therapeutics Inc | MLYS | 0.750% | ||
| 70 | Arcus Biosciences Inc | RCUS | 0.710% | ||
| 71 | Celldex Therapeutics Inc | CLDX | 0.710% | ||
| 72 | Syndax Pharmaceuticals Inc | SNDX | 0.710% | ||
| 73 | Arcutis Biotherapeutics Inc | ARQT | 0.700% | ||
| 74 | Agios Pharmaceuticals Inc | AGIO | 0.690% | ||
| 75 | Disc Medicine Inc | IRON | 0.680% | ||
| 76 | Viridian Therapeutics Inc | VRDN | 0.680% | ||
| 77 | Immunome Inc | IMNM | 0.660% | ||
| 78 | Adma Biologics Inc Com | ADMA | 0.650% | ||
| 79 | Novavax Inc | NVAX | 0.650% | ||
| 80 | Iovance Biotherapeutics Inc | IOVA | 0.560% | ||
| 81 | Biohaven Ltd | BHVN | 0.560% | ||
| 82 | Absci Corp | ABSI | 0.550% | ||
| 83 | Nurix Therapeutics Inc | NRIX | 0.540% | ||
| 84 | Palvella Therapeutics Inc | PVLA | 0.530% | ||
| 85 | Hyperliquid Strategies Inc | PURR | 0.510% | ||
| 86 | Kodiak Sciences Inc | KOD | 0.510% | ||
| 87 | Vericel Corp | VCEL | 0.510% | ||
| 88 | Stoke Therapeuti | STOK | 0.470% | ||
| 89 | Anaptysbio Inc | ANAB | 0.450% | ||
| 90 | Capricor Therapeutics Inc | CAPR | 0.450% | ||
| 91 | Monte Rosa Therapeutics Inc | GLUE | 0.450% | ||
| 92 | Vir Biotechnology Inc | VIR | 0.450% | ||
| 93 | Corvus Pharmaceuticals Inc | CRVS | 0.410% | ||
| 94 | Cullinan Therapeutics Inc | CGEM | 0.390% | ||
| 95 | Tyra Biosciences Inc | TYRA | 0.390% | ||
| 96 | Avalo Therapeuti | AVTX | 0.370% | ||
| 97 | Ardelyx Inc | ARDX | 0.360% | ||
| 98 | Inhibrx Biosciences Inc | INBX | 0.360% | ||
| 99 | Precigen Corp | PGEN | 0.360% | ||
| 100 | Annexon Inc | ANNX | 0.340% | ||
| 101 | Mannkind Corp. | MNKD | 0.330% | ||
| 102 | Oric Pharmaceuticals, Inc. Series C | ORIC | 0.330% | ||
| 103 | Taysha Gene Therapies Inc | TSHA | 0.330% | ||
| 104 | Zenas Biopharma Inc | ZBIO | 0.330% | ||
| 105 | Olema Pharmaceuticals Inc | OLMA | 0.320% | ||
| 106 | Vor Biopharma Inc | VOR | 0.320% | ||
| 107 | Kura Oncology Inc | KURA | 0.310% | ||
| 108 | Jade Biosciences Inc | JBIO | 0.300% | ||
| 109 | Caredx Inc | CDNA | 0.300% | ||
| 110 | Bicara Therapeutics, Inc. | BCAX | 0.290% | ||
| 111 | Geron Corp | GERN | 0.290% | ||
| 112 | Replimune Group Inc Com | REPL | 0.290% | ||
| 113 | ARRIVENT BIOPHARMA INC | AVBP | 0.280% | ||
| 114 | Cytomx Therapeutics Inc | CTMX | 0.280% | ||
| 115 | Janux Therapeutics Inc | JANX | 0.270% | ||
| 116 | Regenxbio Inc | RGNX | 0.270% | ||
| 117 | Sana Biotechnology Inc Common Stock Usd.0001 | SANA | 0.260% | ||
| 118 | Sionna Therapeutics Inc | SION | 0.260% | ||
| 119 | Solid Biosciences Inc | SLDB | 0.260% | ||
| 120 | Xencor Inc | XNCR | 0.260% | ||
| 121 | Rigel Pharmaceuticals Inc | RIGL | 0.240% | ||
| 122 | Allogene Therapeutics Inc | ALLO | 0.230% | ||
| 123 | Altimmune Inc | ALT | 0.230% | ||
| 124 | Ironwood Pharmaceuticals Inc | IRWD | 0.220% | ||
| 125 | Damora Therapeutics Inc | DMRA | 0.200% | ||
| 126 | Immix Biopharma Inc | IMMX | 0.200% | ||
| 127 | Candel Therapeutics Inc. | CADL | 0.190% | ||
| 128 | 4d Molecular Therapeutics Inc. | FDMT | 0.190% | ||
| 129 | Ocugen Inc. | OCGN | 0.190% | ||
| 130 | Prime Medicine Inc Common Stock USD.00001 | PRME | 0.190% | ||
| 131 | Savara Inc | SVRA | 0.180% | ||
| 132 | Arbutus Biopharma Corp. | ABUS | 0.170% | ||
| 133 | First Tracks Biotherapeutics, Inc. | TRAX | 0.170% | ||
| 134 | Myriad Genetics, Inc. | MYGN | 0.170% | ||
| 135 | ARS Pharmaceuticals Inc | SPRY | 0.170% | ||
| 136 | Maplight Therapeutics Inc | MPLT | 0.160% | ||
| 137 | Cabaletta Bio Inc | CABA | 0.150% | ||
| 138 | COMPASS THERAPEUTICS INC | CMPX | 0.140% | ||
| 139 | Verastem Inc | VSTM | 0.140% | ||
| 140 | Emergent Biosolutions Inc | EBS | 0.130% | ||
| 141 | Perspective Ther | CATX | 0.130% | ||
| 142 | Vanda Pharmaceuticals Inc | VNDA | 0.130% | ||
| 143 | Prothena Corporation Public Limited Company Ordinary Shares | PRTA:IE | 0.130% | ||
| 144 | Ovid Therapeutics Inc | OVID | 0.120% | ||
| 145 | Mimedx Group Inc Com | MDXG | 0.110% | ||
| 146 | Lexeo Therapeutics Inc - Series B | LEXO | 0.100% | ||
| 147 | Achieve Life Sciences Inc | ACHV | 0.080% | ||
| 148 | Sagimet Biosciences Inc | SGMT | 0.070% | ||
| 149 | Contra Metsera Inc | - | 0.070% | ||
| 150 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.060% | ||
| 151 | State Street Institutional US Government Money Market Fund | GVMXX | 0.040% | ||
| 152 | Ping An Insu Ran Ce Group Co. Of C Hin A Ltd. | 601318:SH | 0.010% | ||
| 153 | Contra Verve Therapeut | - | 0.010% | ||
| 154 | Contra Inhibrx Inc | - | 0.010% | ||
| 155 | Contra Akero Therapeut Common Stock | - | 0.010% | ||
| 156 | Atrium Therapeutics Inc | RNA | 0.000% | ||
| 157 | Omniab Inc 12.5 Earnout | OABI | 0.000% | ||
| 158 | Omniab Inc 15.00 Earnout | OABI | 0.000% | ||
| 159 | US Dollar | - | 0.000% | ||
| 160 | Contra Blueprint Medic | - | 0.000% |












































